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Introduction 
Dithranol (anthralin) is one of the most widely used and effective, albeit empirical, 
topical treatments for patients with psoriasis. The molecular basis of its mode of action is 
still unknown, but it is probably related to the redox activity leading to the production of 
free radicals, including oxygen radicals. A recent study showed that dithranol 
accumulated in keratinocyte mitochondria (McGill et al., 2005), induced structural 
damage, and interfered with the redox status of the endogenous ubiquinone pool at the 
level of the ubisemiquinone anion. These events lead to increased generation of reactive 
oxygen species and eventually resulted in apoptosis. 
There are some indications that either or both epidermal proliferation and/or 
keratinization and cutaneous inflammation may be crucial in the antipsoriatic effect of 
dithranol; indeed, the often serious inflammation and the irritative response of the 
perilesional or uninvolved skin are the most serious limitations to its use. The extent of 
such inflammation on the peripheral nerves has been successfully demonstrated 
immunohistochemically by the use of the ubiquitin carboxyl-terminal hydrolase L1 
(UCH-L1; gene aliases: pan-neuronal marker protein gene product (PGP) 9.5, ubiquitin 
thiolesterase, PARK5), a cytosolic deubiquitinating enzyme that is highly expressed both 
in humans and in animals. UCH-L1 immunoreactivity was decreased in the oral mucosa 
of patients with chronic inflammation caused by oral lichen planus, after the intradermal 
injection of capsaicin, in leprosy skin and around the sweat glands in palmoplantar 
pustulosis. In animals, the expression of UCH-L1 was absent in necrotic areas of the 
colon of rats treated with 2,4,6-trinitrobenzenesulfonic acid to induce experimental 
colitis, and its immunoreactivity was decreased in rats with nasosinusitis infected 
artificially with Staphylococcus bacteria. Interestingly, psoriasis, an  inflammatory skin 
disorder often treated with dithranol, was reported to be accompanied by either decreased 
or unchanged UCH-L1 immunoreactivity in the affected skin. In light of these conflicting 
results, we investigated whether the inflammation elicited by dithranol would affect the 
UCH-L1 immunoreactivity of the cutaneous nociceptive sensory fibers of the rat 
orofacial skin. 
Deep and cutaneous orofacial tissue inflammation or painful temporomandibular 
disorders often elicit prolonged neuronal activation in the trigeminal nociceptive 
pathways that can lead to chronic pain, and they are therefore of paramount clinical 
importance. A large number of data are available on the molecular, cellular and system-
wide mechanisms involved in the development of, or the amelioration of pain related to, 
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inflammation in the central nervous system (CNS). Nociceptive and pain-related 
information, mediated via different intracellular signalization processes, is transmitted 
and regulated at different levels of the CNS; from the point of view of our studies, the 
most important ones are those that shed light on the roles played by calmodulin (CaM) 
and its target proteins in the responses of the nervous tissue to the inflammatory stimuli. 
CaM, a ubiquitous, multifunctional cytoplasmic calcium (Ca2+) receptor protein 
encoded by three different genes in mammals, is especially abundant in the mammalian 
central nervous system. Its regional distribution and expression pattern in the developing 
and adult rodent brain have been well documented. The expression patterns 
corresponding to the three CaM genes displayed a widely differential distribution for the 
CaM gene-specific mRNA populations throughout the brain and spinal cord. 
As CaM exerts its biological action through its target proteins that are involved in a 
number of cellular regulator processes, it is not surprising that immunohistochemical and 
in situ hybridization studies have demonstrated that CaM immunoreactivity or CaM 
gene-specific transcripts are often colocalized with those of the target enzymes of CaM 
within the same neuronal structures, not only in general, but in the brain stem-medulla 
region in particular. However, in spite of the number of neuronal functions associated 
with midbrain–brain stem structures and regulated by CaM-dependent mechanisms, there 
are only sporadic data on the distribution of CaM protein in this brain region. Since CaM 
plays an important role in regulating a key target protein, Ca2+/CaM kinase II, in a 
number of neuronal functions related to the trigeminal system, including inflammation, 
neuropathic pain and nerve injury, a precise, high-resolution mapping of the CaM gene 
expression could promote a deeper understanding of the functioning of the trigeminal 
system in health and disease. In this study, involving quantitative in situ hybridization 
analysis through the use of CaM gene-specific [35S]-labeled cRNA probes, we also report 
on the differences in CaM gene expression patterns seen along the rostrocaudal axis 
within each nucleus of the trigeminal system. 
Understanding the distribution of CaM expressing cells in normal, physiological 
situation helped us to detect and understand the changes in the regulation of CaM gene 
expression patterns after chronic peripheral skin, in this case orofacial, inflammation. We 
thus set up experiments to map the changes in CaM gene expresion patterns associated 
with chronic dithranol and subsequent corticosteroid treatments in the trigeminal system 
of the adult rat. 
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Specific aims 
Our objective was to document the histological, immunohistological and Western blot 
characteristics of the inflamed orofacial skin after chronic dithranol treatment and 
corticosteroid reversal, and to localize and differentiate CaM mRNA populations 
transcribed from the multiple CaM genes in the different parts of the rat trigeminal 
system after chronic inflammation of the infraorbital region of the orofacial skin by 
means of hybridization of transcript-specific riboprobes labeled with [35S]UTP. 
Specifically, our aims were as follows: 
 
1) To investigate the histochemical characteristics of the inflammation elicited by chronic 
dithranol treatment alone or in combination with corticosteroids, and of the UCH-L1 
immunoreactivity of the cutaneous nociceptive sensory fibers of the rat orofacial skin 
after such treatment. 
2) To localize, differentiate and semiquantitatively analyze in detail the different CaM 
mRNA populations transcribed from the multiple CaM genes in the adult normal rat 
midbrain–brain stem region, 
3) and the possible rostrocaudal gradient by gene-specific [35S]UTP- or DIG-labeled 
cRNA probes. 
4) To localize and differentiate CaM mRNA populations transcribed from the multiple 
CaM genes in two prominent nuclei of the rat trigeminal system, namely the motor 
trigeminal (Mo5) and the principal sensory trigeminal (Pr5) nuclei, after chronic 
inflammation and reversal by corticosteroids of the infraorbital region of the orofacial 
skin by means of quantitative in situ hybridization. 
 
Results 
Dithranol has been used to treat psoriasis for decades. Although its beneficial effect may 
involve the induction of cutaneous inflammation, and inflammation often leads to 
damages in nerve fibers in the periphery or, consequently, in the central nervous system 
as well, these alterations, especially those that elicit neuronal adaptation or regulation of 
neuronal gene expression, are not well documented. Therefore, we investigated the 
effects of chronic dithranol treatment and subsequent corticosteroid treaatment 1) on the 
immunohistochemical and Western blot characteristics of the cutaneous nerve fibers in 
the rat skin, where the epidermal nerve fiber component ubiquitin carboxyl-terminal 
hydrolase L1 (UCH-L1) was used as target antigene, and 2) on the regulation of 
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calmodulin (CaM) gene expression on the different components of the rat trigeminal 
system in the midbrain–brain stem region; we used in situ hybridization techniques to 
detect gene-specific [35S]- and digoxigenin-labeled cRNA probes complementary to the 
multiple CaM mRNAs. The results of radioactive and color in situ hybridization 
histochemistries were analyzed with (semi)quantitative image processing techniques. 
Chronic dithranol treatment for 5 days resulted a complete loss of UCH-L1 
immunoreactivity. Topical application of corticosteroid onto the inflamed skin for 5 days 
reversed this effect: the UCH-L1 immunoreactivity was almost completely restored. 
Steroid treatment for 5 days did not change the appearance of the UCH-L1-
immunoreactive nerve fibers. These findings were supported by Western blot analyses. 
We concluded that dithranol, incidentally similarly to psoriasis, causes inflammation and 
abolishes UCH-L1 immunoreactivity in the rat orofacial skin in a corticosteroid-
reversible manner. This phenomenon may be due to the ability of dithranol to cause 
oxidative damage to the UCH-L1 protein, and to the antioxidant activity of the 
corticosteroids countering this effect. 
 The different CaM genes were widely expressed throughout the midbrain–brain 
stem region with moderate intensities in control animals. In spite of the similar general 
outline, significant differences in the distributions of the multiple CaM mRNA species 
were found in certain areas. In general, the CaM III mRNAs were most abundant, 
followed by the CaM I and CaM II mRNA populations. Most of the transcripts was found 
in the neuronal somata comprising the medullar nuclei, while much less label was 
detected in the neuropil. The CaM III mRNAs were more than 2.5 times more abundant 
than the CaM II mRNAs in the nucleus of the trapezoid body, and more than 2 times 
more abundant in the motor trigeminal nucleus, the principal sensory trigeminal nucleus 
and the olivary nucleus. The CaM III mRNAs were less dominant in the medial 
lemniscus, the inferior colliculus and the pontine reticular nucleus than those of the other 
CaM gene-specific transcripts. The CaM mRNA levels were low to moderate, without 
significant differences, in the mesencephalic trigeminal nucleus (Me5). The differential 
control of the expression of the CaM genes may thus contribute to the regulation of the 
multiple neuronal functions linked to this complex brain region and regulated by different 
CaM-dependent mechanisms via its target proteins. 
The quantitative analysis of the expression patterns of the three CaM genes showed 
that significant differences in the amounts of the transcripts of some CaM genes were 
present between the rostral and caudal parts of the individual nuclei of the trigeminal 
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system in control animals. In most cases, the CaM gene-specific transcripts displayed a 
clear differential distribution along the rostrocaudal axis: they were more abundant in the 
rostral parts of these nuclei. For example, the levels of mRNAs transcribed from each of 
the CaM I, II and III genes were significantly higher in the rostral part of the principal 
sensory trigeminal nucleus (Pr5), while the rostral part of the motor trigeminal nucleus 
(Mo5) exhibited an elevated amount of transcripts for the CaM I gene only. Interestingly, 
the CaM II mRNAs were most abundant in the caudal part of the Me5. Moreover, the 
largest difference between any of the CaM gene-specific transcript contents of the rostral 
and caudal parts was found for those of the CaM II gene in the Pr5. Here, the intranuclear 
difference was about 50%, the rostral part being the richer in CaM II mRNAs. Our results 
draw attention to the possible causal relation between the differences in the neuronal 
circuitry of the rostral and caudal parts of these nuclei and their differential CaM gene 
expression. This somatotopy may have important functional implications. 
The cutaneous and mucosal surfaces in the infraorbital region around the whisker 
pad are innervated by the maxillary division of the afferent fibers of the trigeminal nerve, 
while certain ganglion cells project to the Pr5. In turn, some of the neurons in the Pr5 
project to the Mo5, whose neurons do not innervate the infraorbital skin. We analyzed the 
CaM gene expression in these nuclei after dithranol-induced inflammation and 
subsequent treatment with corticosteroid in the infraorbital skin. CaM gene-specific 
mRNA populations were detected through quantitative image analysis of the distribution 
of CaM gene-specific riboprobes in brain stem cryostat sections of control rats and rats 
chronically treated with dithranol, corticosteroid or both. These nuclei displayed a 
differentially altered CaM gene expression in response to the treatments. While the CaM 
I and II mRNA contents were increased, the CaM III transcripts remained unaltered after 
chronic dithranol treatment in the Mo5. In the Pr5, however, the CaM mRNA contents 
were either unchanged (CaM I and III) or increased (CaM II). Subsequent corticosteroid 
treatment reversed the stimulatory effects of dithranol on the expression of all the CaM 
genes in the Mo5, but was without significant effects on the CaM I and II genes, or even 
increased the CaM III mRNA contents in the Pr5. Corticosteroid treatment alone was 
either ineffective or decreased the levels of CaM mRNAs in these nuclei. These data 
suggest that peripheral noxae of dermal origin may result in a trans-synaptically acting 
differential regulation of the multiple CaM genes in the brain. 
 
Conclusions 
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Our results draw attention to a possible causal relation between the differences in afferent 
and efferent neuronal connections (and consequently in their presumably segregated 
functions) of the rostral and caudal parts of the trigeminal nuclei and their differential 
CaM gene expression. In light of the above data, our present findings can be interpreted 
as trans-synaptic regulatory responses of the CaM gene expression to two opposing 
effects: the effect of dithranol in degrading proteins that include CaM and the 
deubiquitinating protein UCH-L1 itself, via its production of free radicals and oxygen 
radicals, which result in a differentially altered CaM gene expression; and the modulatory 
(generally inhibitory) effect of the corticosteroids on the CaM gene expression, resulting 
in a decreased transcription of the CaM genes. These data provide evidence that chronic 
inflammation and subsequent corticosteroid treatment can influence the neuronal CaM 
gene expression through multiple synaptic contacts. Long-lasting changes elicited in the 
periphery by chronic noxious stimuli (e.g. inflammatory processes or their treatment with 
steroids) through the peripheral nerves could elicit alterations in, and therefore influence, 
the CNS functions. These stressors may be important components in the regulatory 
mechanisms of neuronal gene expression as they could result in transneuronal plasticity, 
where compensatory increases or decreases in the multiple CaM genes occur in the Pr5 
and Mo5. 
Collectively, these findings suggest that the differential regulation of the CaM 
genes in these projection sites are ipsilaterally and trans-synaptically modulated, perhaps 
via multiple signaling pathways. However, the precise molecular mechanisms underlying 
this often opposing regulation are unknown. 
 
Summary of the findings 
1) Chronic dithranol treatment of the orofacial skin resulted in a complete loss of the 
UCH-L1 immunoreactivity in the cutaneous nerves. Subsequent steroid treatment 
restored UCH-L1 immunoreactivity in these structures. These findings were 
supported by Western blot analyses. 
2) In situ hybridization of radioactive cRNA probes specific for CaM I, II and III 
genes revealed a specific and unique distribution of their transcripts in this brain 
area. In general, the rank order of abundance in the nuclei of the midbrain–brain 
stem region investigated was CaM III > CaM I > CaM II. Color in situ 
hybridization demonstrated many, primarily medium-sized multipolar neurons in 
the medullar nuclei. 
 8 
3) For some CaM genes, significant differences in the amounts of their transcripts 
were found between the rostral and caudal parts of the individual nuclei of the 
trigeminal system. In most cases, the CaM gene-specific transcripts were more 
abundant in the rostral parts of the nuclei, while the rostral part of the motor 
trigeminal nucleus displayed an elevated amount of transcripts for the CaM I 
gene only. 
4) Chronic dithranol treatment of the infraorbital skin selectively affected the CaM 
gene expression in selected parts of this brain region: an area-dependent and 
gene-specific differential regulation of CaM gene expression was demonstrated in 
two nuclei of the trigeminal system, the Mo5 and the Pr5 of the rat, as evidenced 
by quantitative in situ hybridization. Moreover, the CaM gene expression was, in 
general, sensitive to corticosteroid treatment, as it differentially lowered the 
amounts of the CaM mRNA populations after chronic dithranol treatment. 
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